DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), today announced that Lymphoseek® (technetium Tc 99m tilmanocept) injection data are scheduled for presentations at the following conferences: American Society of Breast Surgeons 16th Annual Meeting in Orlando, FL, and 2015 American Head & Neck Society Annual Meeting & Translational Research Meeting, held during the Combined Otolaryngology Spring Meetings (COSM) in Boston, MA. Details of the presentations are listed below.
Help employers find you! Check out all the jobs and post your resume.
